– Interview with Martina Buck, Ph.D., Assistant Professor of Medicine and Researcher at UC San Diego’s Department of Medicine and Moores UCSD Cancer Center

Previous articleInvestigators Get Around Taxol-Resistance Using an Arginine Transporter
Next articleBristol-Myers Squibb Shells Out $30M Upfront for PDL Biopharma’s Early-Stage Cancer Drug